View Document Preview and Link Open Document File Size: 161,61 KB Share Result on Facebook
City Leeds / London / Edinburgh / / Company AEs / Cephalon / NIHR Horizon Scanning Centre TARGET GROUP / ADVANTAGES If / CURRENT TREATMENT / Teva / Sponsor Teva Pharmaceutical Industries / DEVELOPER Teva Pharmaceuticals Limited. / / Continent America / Europe / / Country United States / Canada / United Kingdom / Scotland / / Currency pence / GBP / / / Event Product Issues / / Facility National Institute / University of Birmingham Email / University of Birmingham / Royal College of Physicians / / IndustryTerm health technology / technology appraisals / nihrhsc@contacts.bham.ac.uk Web / technology appraisal guidance / inhaler systems / literature search / technology appraisal / / MarketIndex Asthma Symptom Utility / / MedicalCondition inflammatory response / Poorly controlled asthma / eosinophilic inflammation / COPD / headache / bronchitis / chronic disorder / nasal polyps / milder asthma / nausea / airway inflammation / respiratory tract infections / Both allergic and non-allergic asthma / fatigue / pulmonary / sinusitis / severe persistent allergic asthma / chronic asthma / wheezing / Asthma / allergic asthma / disease / nasopharyngitis / upper respiratory infections / chronic obstructive pulmonary disease / chronic / clinical asthma / coughing / blister / chest tightness / PATIENT GROUP BACKGROUND Asthma / eosinophilic asthma / inflammation / diagnosed asthma / depression / severe eosinophilic asthma / severe asthma / bronchoconstriction / fibrosis / / Organization British Thoracic Society / University of Birmingham Email / Horizon Scanning Centre / NIHR Horizon Scanning Centre / University of Birmingham / National Institute for Health Research / European Union / Department of Health / NHS / Institute for Health / / Position consultant / author / Governor / / Product Fluticasone propionate / beta2 / Mometasone furoate / theophylline / Xolair / control / / PublishedMedium The National Review / Scientific Journal / / Technology health technology / / URL http / SocialTag 
Horizon Scanning Centre March 2015 Reslizumab for eosinophilic asthma SUMMARY